Abstract:Brett Hauber, 1 Mark V Hand, 2 Bruno C Hancock, 3 Joseph Zarrella, 3 Ljiljana Harding, 4 Michaela Ogden-Barker, 5 Amy S Antipas, 3 Stephen J Watt 1 1 Pfizer Inc, New York, NY, USA; 2 Pfizer Ireland Pharmaceuticals, Ballintaggart, Cork, Ringaskiddy, Ireland; 3 Pfizer Inc, Groton, CT, USA; 4 Pfizer ApS, Ballerup, Denmark; 5 Pfizer Ltd, Sandwich, England, UK Correspondence: Brett Hauber, Pfizer Inc, 66 Hudson Boulevard, New York, NY, 10018, USA, Tel +16102359462, Email Background: There is no consistent framework for patient-centric drug product design, despite the common understanding that drug product acceptability and preferences influence adherence and, therefore, drug product effectiveness. The aim of this review was to assess current understanding of patient acceptability and preferences for solid oral dosage form (SODF) drug product attributes, and the potential impact of these attributes on patient behaviors and outcomes. Patients and Methods: A scoping review was conducted. Embase, Ovid MEDLINE ® , and PubMed ® were searched for full-text articles published between January 2013 and May 2023. Following screening and assessment against predefined inclusion criteria, data were analyzed thematically. Results: Nineteen studies were included. Four overarching domains of drug product attributes were identified and summarized in a framework: appearance, swallowability, palatability, and handling. Each domain was informed by specific drug product attributes: texture, form, size, shape, color, marking, taste, mouthfeel, and smell. The most frequently studied domains were swallowability and appearance, while the most studied attributes were size, shape, and texture. Smell, marking, and mouthfeel were the least studied attributes. Texture intersected all domains, while form, shape, and size intersected appearance, swallowability, and handling. Swallowability and size appeared to be the key domain and attribute, respectively, to consider when designing drug products. Few studies explored the impact of drug product attributes on behaviors and outcomes. Conclusion: While existing studies of drug product attributes have focused on appearance and swallowability, this review highlighted the importance of two less well-understood domains—palatability and handling—in understanding patients' acceptability and preferences for SODF drug products. The framework provides a tool to facilitate patient-centric design of drug products, organizing and categorizing physical drug product attributes into four overarching domains (appearance, swallowability, palatability, and handling), encouraging researchers to comprehensively assess the impact of drug product attributes on patient acceptability, preferences, and outcomes. Plain Language Summary: Medicines come in a variety of types and forms. These include tablets and capsules. Factors, such as the size and shape of tablets, can affect how people take medicines. However, patients are rarely involved in designing the medicines that they take. In this study, researchers summarized 19 studies published between 2013 and 2023. They wanted to understand how different factors, like size and shape, affect patients' preferences, ability, and willingness to take medicines. Researchers focused on the "physical" aspects of medicines and found 4 common themes: 1) what they look like (appearance), 2) how easy they are to swallow (swallowability), 3) how they taste and feel in the mouth (palatability), and 4) how easy they are to handle (handling). Eight factors were also found: color, markings, shape, size, smell, taste, texture, and how a medicine feels in the mouth (mouthfeel). Most studies focused on what medicines look like and how easy they are to swallow. The factors that researchers mostly looked at were the size, shape, and texture of medicines. The design of medicines can impact patients of different ages, though there may be specific needs for certain groups of patients, including children, older adults, and people with certain diseases. Patient input should become a part of future medicines design to ensure their acceptability. Keywords: preference, acceptability, formulation, drug product attributes, drug product design There is increasing recognition and desire to shift from drug-centric to patient-centric design models, 1,2 whereby the comprehensive needs of patients are identified and inform drug product design. 3–6 This has been exemplified by the Innovative Medicines Initiative-PREFER project, which has focused on integrating patient preferences throughout the medical product lifecycle. 7 Pa -Abstract Truncated-

Formulation approaches in enhancement of patient compliance to oral drug therapy

Dosage form Design: From concept to Compliance - Navigating Regulatory Standards and Patient needs

A Comprehensive Review of Challenges in Oral Drug Delivery Systems and Recent Advancements in Innovative Design Strategies

Drug complexes: Perspective from Academic Research and Pharmaceutical Market

"Enhancing Oral Drug Absorption: Overcoming Physiological and Pharmaceutical Barriers for Improved Bioavailability"

Recent innovations in oral drug delivery systems: Examining current challenges and future opportunities for enhanced therapeutic efficacy

Advances in Oral Drug Delivery

Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems

Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs

Insight into Delivery Approaches for Biopharmaceutics Classification System Class II and IV Drugs

Formulation Challenges and Strategies to Develop Pediatric Dosage Forms

Overall Review On Permeation Enhancers in Drug Delivery Systems

Rationale and strategies for formulation development of oral fixed dose combination drug products

Review Article: Exploring Strategies To Improve Treatment Outcomes And Compliance In Specific Patient Groups With Acid-Related Disorders

PREFERRED PHARMACEUTICAL FORMULATIONS BY PATIENTS SUFFERING FROM SEXUAL DYSFUNCTION VISITING PSYCHIATRY OUT PATIENT DEPARTMENT IN AN TERTIARY CARE CENTER

Oral Bioavailability: Issues and Solutions via Nanoformulations

Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review

Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals

An overview on dosage forms and formulation strategies for vaccines and antibodies oral delivery

Novel omeprazole delayed release orally disintegrating tablets for enhanced patient compliance: a case of model informed formulation development

Patients' Preference for Pharmaceutical Dosage Forms: Does It Affect Medication Adherence? A Cross-Sectional Study in Community Pharmacies